Ipilimumab associated colitis: an IpiColitis case series at MedStar Georgetown University Hospital. - Wikidata - wikimedia - TriplyDB

Ipilimumab associated colitis: an IpiColitis case series at MedStar Georgetown University Hospital.

Ipilimumab associated colitis: an IpiColitis case series at MedStar Georgetown University Hospital.

http://www.wikidata.org/entity/Q35375801

about

Immune checkpoint inhibitors side effects and management.Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management.Histopathological and Immunophenotypic Features of Ipilimumab-Associated Colitis Compared to Ulcerative Colitis.Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice.Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor-Induced Enteritis.Severe Gastritis after Administration of Nivolumab and Ipilimumab

P2860

Q38878899-3C4C6FA6-03CF-4A8B-8CE9-72F72095A955 Q39328076-9C3E4624-10E1-405E-A3E4-8B8C79AD7219 Q49719593-D5187B1D-7D3B-4D02-AD2B-B6188262C0FF Q53695267-8BD56F69-2AD9-4D96-A93A-C90EF09879B8 Q55074178-8C9FB0E7-42ED-43CF-8027-2C69B77B0304 Q58768111-89D40C4D-4D09-4ADA-B9D4-09AA23C0BF1A

P2860

Ipilimumab associated colitis: an IpiColitis case series at MedStar Georgetown University Hospital.

http://www.wikidata.org/entity/Q35375801

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Ipilimumab associated colitis: ...... eorgetown University Hospital.

@ast

Ipilimumab associated colitis: ...... eorgetown University Hospital.

@en

type

label

Ipilimumab associated colitis: ...... eorgetown University Hospital.

@ast

Ipilimumab associated colitis: ...... eorgetown University Hospital.

@en

prefLabel

Ipilimumab associated colitis: ...... eorgetown University Hospital.

@ast

Ipilimumab associated colitis: ...... eorgetown University Hospital.

@en

P1433

Q35375801-8B4EDEEC-C367-4C08-9FD9-DFA671241177

P1476

Q35375801-D2BEA2D0-391F-4F81-8018-8C4FEA69C4C1

P2093

Q35375801-028EF3E4-039D-445D-96EA-05BD870828A1

Q35375801-04B266BC-5628-49DD-8056-FFECC89D8F83

Q35375801-38BE6C0B-CDC7-4754-829B-A6BDA70DB204

Q35375801-AB73743D-86A6-48B1-B4FD-6EDE2102B560

Q35375801-C27C9F90-92A1-4750-BE91-31CF0E1931CE

P2860

Q35375801-2CDF8FE3-FC0A-4380-B5C5-86B38BDA148D

Q35375801-405FB6A3-7B26-4E61-A4D5-97404152165A

Q35375801-6E61170C-926B-4F52-A6F9-7DAFCE829B31

Q35375801-93A7C830-9B77-48DD-8721-B0F55791FCBB

Q35375801-95358880-F7D0-4D3B-B13E-F7BE9550FF7C

Q35375801-9D5BD239-9DB9-4D6F-8800-4071D6A734ED

Q35375801-EEAA54B8-B39E-4B50-BA07-163D422EE71F

Q35375801-F0F6676B-58BE-43AE-8433-BC065518754F

P304

Q35375801-4B897650-BDA6-4C74-A5A7-FA56CA05C7D3

P31

Q35375801-898C4DAA-0B6C-494F-9BF9-1F24BB08F0BA

Q35375801-d123562b-87b6-4bba-b620-bcef304c823b

P356

Q35375801-F4CD8461-D201-42F8-8ABC-437DD6D78544

P407

Q35375801-7D17F3E4-FE71-483B-9EA0-220EA160F310

P433

Q35375801-045334D0-E8D2-447A-9D31-DE745F452A70

P478

Q35375801-231D636D-634C-45CE-9E36-7570BFC3D2A7

P577

Q35375801-0BA1C3C4-7233-468A-9FA1-EB86B192219B

P5875

Q35375801-58940CDA-F610-46F0-9E25-AD8C496A555E

P698

Q35375801-D422342F-896E-49D7-93B4-18CF1C09AF80

P921

Q35375801-D200F4AB-FC9A-4977-A384-33A3278217CA

P932

Q35375801-6B9A437A-F155-434B-A90A-66771CC271EA

P356

WJG.V21.I14.4373

P1433

World Journal of Gastroenterology

P1476

Ipilimumab associated colitis: ...... eorgetown University Hospital.

@en

P2093

Aline J Charabaty

http://www.w3.org/2001/XMLSchema#string

Mark C Mattar

http://www.w3.org/2001/XMLSchema#string

Michael B Atkins

http://www.w3.org/2001/XMLSchema#string

Mohamed Sultan

http://www.w3.org/2001/XMLSchema#string

Pawan Rastogi

http://www.w3.org/2001/XMLSchema#string

P2860

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis.

Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma.

Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.

Types of colitis based on histology.

The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: summary of the scientific assessment of the Committee for Medicinal Products f

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma.

Ipilimumab-induced acute severe colitis treated by infliximab.

P304

4373-4378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I14.4373

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275217596

http://www.w3.org/2001/XMLSchema#string

P698

25892889

http://www.w3.org/2001/XMLSchema#string

P921

P932

4394100

http://www.w3.org/2001/XMLSchema#string